Johnson & Johnson (NYSE: JNJ) kicked off on Tuesday, up 0.32% from the previous trading day, before settling in for the closing price of $186.26. Over the past 52 weeks, JNJ has traded in a range of $140.68-$194.48.
Annual sales at Healthcare sector company grew by 0.55% over the past five years. While this was happening, its average annual earnings per share was recorded 8.89%. With a float of $2.41 billion, this company’s outstanding shares have now reached $2.41 billion.
Let’s look at the performance matrix of the company that is accounted for 139800 employees.
Johnson & Johnson (JNJ) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Johnson & Johnson is 0.12%, while institutional ownership is 73.75%. The most recent insider transaction that took place on Oct 17 ’25, was worth 4,185,793. In this transaction EVP, Innovative Medicine, R&D of this company sold 21,721 shares at a rate of $192.71, taking the stock ownership to the 10,658 shares. Before that another transaction happened on Oct 17 ’25, when Company’s Officer proposed sale 21,721 for $192.71, making the entire transaction worth $4,185,794.
Johnson & Johnson (JNJ) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 2.04 earnings per share (EPS), higher than consensus estimate (set at 2.01) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.38% during the next five years compared to 0.55% growth over the previous five years of trading.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Take a look at Johnson & Johnson’s (JNJ) current performance indicators. Last quarter, stock had a quick ratio of 0.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.89. Likewise, its price to free cash flow for the trailing twelve months is 22.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 10.36, a number that is poised to hit 2.53 in the next quarter and is forecasted to reach 11.51 in one year’s time.
Technical Analysis of Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE: JNJ) saw its 5-day average volume 8.23 million, a negative change from its year-to-date volume of 8.88 million. As of the previous 9 days, the stock’s Stochastic %D was 28.59%.
During the past 100 days, Johnson & Johnson’s (JNJ) raw stochastic average was set at 83.23%, which indicates a significant increase from 22.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.36 in the past 14 days, which was lower than the 2.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $183.67, while its 200-day Moving Average is $165.18. Nevertheless, the first resistance level for the watch stands at $187.91 in the near term. At $188.97, the stock is likely to face the second major resistance level. The third major resistance level sits at $190.11. If the price goes on to break the first support level at $185.71, it is likely to go to the next support level at $184.57. The third support level lies at $183.51 if the price breaches the second support level.
Johnson & Johnson (NYSE: JNJ) Key Stats
The company with the Market Capitalisation of 450.20 billion has total of 2,409,295K Shares Outstanding. Its annual sales at the moment are 88,821 M in contrast with the sum of 14,066 M annual income. Company’s last quarter sales were recorded 23,993 M and last quarter income was 5,152 M.
